Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases

Free Radical Biology and Medicine

Volumn 44, Issue 7, 2008, Pages 1259-1272

  Mantena, Sudheer K ^a   King, Adrienne L ^a   Andringa, Kelly K ^a   Eccleston, Heather B ^a   Bailey, Shannon M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

AFLD; Alcohol; Antioxidants; ASH; Free radicals; Liver; Mitochondria; NAFLD; NASH; Nitric oxide; Obesity; Oxidative stress; Proteomics; Steatosis

Indexed keywords

ALCOHOL; ANTIOXIDANT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE;

ALCOHOLIC FATTY LIVER; BIOENERGY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HEREDITY; HUMAN; LIPOGENESIS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR;

ALCOHOLS; ANIMALS; ANTIOXIDANTS; DISEASE PROGRESSION; FATTY ACIDS; FATTY LIVER; FIBROSIS; FREE RADICALS; HEPATOCYTES; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; OBESITY; OXIDATIVE STRESS; PROTEOMICS;

EID: 40949141493     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.12.029     Document Type: Review

References (196)

1. Centers for Disease Control and Prevention. Alcohol-attributable death and years of potential life lost-United States, 2001. MMWR Morb. Mortal. Wkly. Rep. 53 (2004) 866-870
2. Bellentani S., Saccoccio G., Costa G., Tiribelli C., Manenti F., Sodde M., Saveria Croce L., Sasso F., Pozzato G., Cristianini G., and Brandi G. Drinking habits as cofactors of risk for alcohol induced liver damage: the Dionysos Study Group. Gut 41 (1997) 845-850
3. Day C.P. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int. 26 (2006) 1021-1028
4. Marrero J.A., Fontana R.J., Fu S., Conjeevaram H.S., Su G.L., and Lok A.S. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J. Hepatol. 42 (2005) 218-224
5. Carmiel-Haggai M., Cederbaum A.I., and Nieto N. Binge ethanol exposure increases liver injury in obese rats. Gastroenterology 125 (2003) 1818-1833
6. Ludwig J., Viggiano T.R., McGill D.B., and Oh B.J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin. Proc. 55 (1980) 434-438
7. Mehta K., Van Thiel D.H., Shah N., and Mobarhan S. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr. Rev. 60 (2002) 289-293
8. Ruhl C.E., and Everhart J.E. Epidemiology of nonalcoholic fatty liver. Clin. Liver Dis. 8 (2004) 501-519 vii
9. Papandreou D., Rousso I., and Mavromichalis I. Update on non-alcoholic fatty liver disease in children. Clin. Nutr. 26 (2007) 409-415
10. Bunout D. Nutritional and metabolic effects of alcoholism: their relationship with alcoholic liver disease. Nutrition 15 (1999) 583-589
11. Howard A.A., Arnsten J.H., and Gourevitch M.N. Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann. Intern. Med. 140 (2004) 211-219
12. van de Wiel A. Diabetes mellitus and alcohol. Diabetes Metab. Res. Rev. 20 (2004) 263-267
13. Begriche K., Igoudjil A., Pessayre D., and Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6 (2006) 1-28
14. Farrell G.C., and Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (2006) S99-S112
15. Feldstein A.E., Werneburg N.W., Canbay A., Guicciardi M.E., Bronk S.F., Rydzewski R., Burgart L.J., and Gores G.J. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40 (2004) 185-194
16. Feldstein A.E., Werneburg N.W., Li Z., Bronk S.F., and Gores G.J. Bax inhibition protects against free fatty acid-induced lysosomal permeabilization. Am. J. Physiol.: Gastrointest. Liver Physiol. 290 (2006) G1339-G1346
17. Wei Y., Wang D., and Pagliassotti M.J. Saturated fatty acid-mediated endoplasmic reticulum stress and apoptosis are augmented by trans-10, cis-12-conjugated linoleic acid in liver cells. Mol. Cell. Biochem. 303 (2007) 105-113
18. Wei Y., Wang D., Topczewski F., and Pagliassotti M.J. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am. J. Physiol: Endocrinol. Metab. 291 (2006) E275-E281
19. Joshi-Barve S., Barve S.S., Amancherla K., Gobejishvili L., Hill D., Cave M., Hote P., and McClain C.J. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 46 (2007) 823-830
20. Landar A., Shiva S., Levonen A.L., Oh J.Y., Zaragoza C., Johnson M.S., and Darley-Usmar V.M. Induction of the permeability transition and cytochrome c release by 15-deoxy-Delta12,14-prostaglandin J2 in mitochondria. Biochem. J. 394 (2006) 185-195
21. Landar A., Zmijewski J.W., Dickinson D.A., Le Goffe C., Johnson M.S., Milne G.L., Zanoni G., Vidari G., Morrow J.D., and Darley-Usmar V.M. Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species. Am. J. Physiol., Heart Circ. Physiol. 290 (2006) H1777-H1787
22. Fromenty B., Robin M.A., Igoudjil A., Mansouri A., and Pessayre D. The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab. 30 (2004) 121-138
23. Kang L., Chen X., Sebastian B.M., Pratt B.T., Bederman I.R., Alexander J.C., Previs S.F., and Nagy L.E. Chronic ethanol and triglyceride turnover in white adipose tissue in rats: inhibition of the anti-lipolytic action of insulin after chronic ethanol contributes to increased triglyceride degradation. J. Biol. Chem. 282 (2007) 28465-28473
24. He L., Marecki J.C., Serrero G., Simmen F.A., Ronis M.J., and Badger T.M. Dose dependent effects of alcohol on insulin signaling: partial explanation for biphasic alcohol impact on human health. Mol. Endocrinol. 21 (2007) 2541-2550
25. He L., Simmen F.A., Mehendale H.M., Ronis M.J., and Badger T.M. Chronic ethanol intake impairs insulin signaling in rats by disrupting Akt association with the cell membrane: role of TRB3 in inhibition of Akt/protein kinase B activation. J. Biol. Chem. 281 (2006) 11126-11134
26. You M., Fischer M., Deeg M.A., and Crabb D.W. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J. Biol. Chem. 277 (2002) 29342-29347
27. You M., Matsumoto M., Pacold C.M., Cho W.K., and Crabb D.W. The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology 127 (2004) 1798-1808
28. Tomita K., Tamiya G., Ando S., Kitamura N., Koizumi H., Kato S., Horie Y., Kaneko T., Azuma T., Nagata H., Ishii H., and Hibi T. AICAR, an AMPK activator, has protective effects on alcohol-induced fatty liver in rats. Alcohol. Clin. Exp. Res. 29 (2005) 240S-245S
29. Xu A., Wang Y., Keshaw H., Xu L.Y., Lam K.S., and Cooper G.J. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Invest. 112 (2003) 91-100
30. You M., Considine R.V., Leone T.C., Kelly D.P., and Crabb D.W. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 42 (2005) 568-577
31. Winder W.W., and Hardie D.G. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am. J. Physiol. 277 (1999) E1-E10
32. Yeon J.E., Califano S., Xu J., Wands J.R., and De La Monte S.M. Potential role of PTEN phosphatase in ethanol-impaired survival signaling in the liver. Hepatology 38 (2003) 703-714
33. Cidad P., Almeida A., and Bolanos J.P. Inhibition of mitochondrial respiration by nitric oxide rapidly stimulates cytoprotective GLUT3-mediated glucose uptake through 5′-AMP-activated protein kinase. Biochem. J. 384 (2004) 629-636
34. Hutchinson D.S., Csikasz R.I., Yamamoto D.L., Shabalina I.G., Wikstrom P., Wilcke M., and Bengtsson T. Diphenylene iodonium stimulates glucose uptake in skeletal muscle cells through mitochondrial complex I inhibition and activation of AMP-activated protein kinase. Cell. Signal. 19 (2007) 1610-1620
35. Zou M.H., Kirkpatrick S.S., Davis B.J., Nelson J.S., Wiles W.G.T., Schlattner U., Neumann D., Brownlee M., Freeman M.B., and Goldman M.H. Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo: role of mitochondrial reactive nitrogen species. J. Biol. Chem. 279 (2004) 43940-43951
36. Pritchard M.T., McMullen M.R., Stavitsky A.B., Cohen J.I., Lin F., Medof M.E., and Nagy L.E. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology 132 (2007) 1117-1126
37. Bykov I., Jauhiainen M., Olkkonen V.M., Saarikoski S.T., Ehnholm C., Junnikkala S., Vakeva A., Lindros K.O., and Meri S. Hepatic gene expression and lipid parameters in complement C3(-/-) mice that do not develop ethanol-induced steatosis. J. Hepatol. 46 (2007) 907-914
38. Yamaguchi K., Yang L., McCall S., Huang J., Yu X.X., Pandey S.K., Bhanot S., Monia B.P., Li Y.X., and Diehl A.M. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45 (2007) 1366-1374
39. Damelin L.H., Coward S., Kirwan M., Collins P., Selden C., and Hodgson H.J. Fat-loaded HepG2 spheroids exhibit enhanced protection from pro-oxidant and cytokine induced damage. J. Cell. Biochem. 101 (2007) 723-734
40. Bailey S.M. A review of the role of reactive oxygen and nitrogen species in alcohol-induced mitochondrial dysfunction. Free Radic. Res. 37 (2003) 585-596
41. Cunningham C.C., Coleman W.B., and Spach P.I. The effects of chronic ethanol consumption on hepatic mitochondrial energy metabolism. Alcohol Alcohol. 25 (1990) 127-136
42. Hoek J.B. Mitochondrial energy metabolism in chronic alcoholism. Curr. Top. Bioenerg. 17 (1994) 197-241
43. Coleman W.B., and Cunningham C.C. Effects of chronic ethanol consumption on the synthesis of polypeptides encoded by the hepatic mitochondrial genome. Biochim. Biophys. Acta 1019 (1990) 142-150
44. Cahill A., Stabley G.J., Wang X., and Hoek J.B. Chronic ethanol consumption causes alterations in the structural integrity of mitochondrial DNA in aged rats. Hepatology 30 (1999) 881-888
45. Cahill A., Wang X., and Hoek J.B. Increased oxidative damage to mitochondrial DNA following chronic ethanol consumption. Biochem. Biophys. Res. Commun. 235 (1997) 286-290
46. Venkatraman A., Landar A., Davis A.J., Chamlee L., Sanderson T., Kim H., Page G., Pompilius M., Ballinger S., Darley-Usmar V., and Bailey S.M. Modification of the mitochondrial proteome in response to the stress of ethanol-dependent hepatotoxicity. J. Biol. Chem. 279 (2004) 22092-22101
47. Cahill A., and Cunningham C.C. Effects of chronic ethanol feeding on the protein composition of mitochondrial ribosomes. Electrophoresis 21 (2000) 3420-3426
48. Patel V.B., and Cunningham C.C. Altered hepatic mitochondrial ribosome structure following chronic ethanol consumption. Arch. Biochem. Biophys. 398 (2002) 41-50
49. Moon K.H., Hood B.L., Kim B.J., Hardwick J.P., Conrads T.P., Veenstra T.D., and Song B.J. Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats. Hepatology 44 (2006) 1218-1230
50. Venkatraman A., Landar A., Davis A.J., Ulasova E., Page G., Murphy M.P., Darley-Usmar V., and Bailey S.M. Oxidative modification of hepatic mitochondria protein thiols: effect of chronic alcohol consumption. Am. J. Physiol.: Gastrointest. Liver Physiol. 286 (2004) G521-G527
51. Chavin K.D., Yang S., Lin H.Z., Chatham J., Chacko V.P., Hoek J.B., Walajtys-Rode E., Rashid A., Chen C.H., Huang C.C., Wu T.C., Lane M.D., and Diehl A.M. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J. Biol. Chem. 274 (1999) 5692-5700
52. Perez-Carreras M., Del Hoyo P., Martin M.A., Rubio J.C., Martin A., Castellano G., Colina F., Arenas J., and Solis-Herruzo J.A. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38 (2003) 999-1007
53. Garcia-Ruiz I., Rodriguez-Juan C., Diaz-Sanjuan T., del Hoyo P., Colina F., Munoz-Yague T., and Solis-Herruzo J.A. Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice. Hepatology 44 (2006) 581-591
54. Yang S.Q., Lin H.Z., Lane M.D., Clemens M., and Diehl A.M. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 2557-2562
55. Yang S.Q., Lin H.Z., Mandal A.K., Huang J., and Diehl A.M. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 34 (2001) 694-706
56. Cortez-Pinto H., Chatham J., Chacko V.P., Arnold C., Rashid A., and Diehl A.M. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 282 (1999) 1659-1664
57. Miyamoto K., and S.W. F. Hepatic adenine nucleotide metabolism measured in vivo in rats fed ethanol and a high fat-low protein diet. Hepatology 8 (1988) 53-60
58. Takahashi H., Geoffrion Y., Butler K.W., and French S.W. In vivo hepatic energy metabolism during the progression of alcoholic liver disease: a noninvasive 31P nuclear magnetic resonance study in rats. Hepatology 11 (1990) 65-73
59. Hoek J.B., Cahill A., and Pastorino J.G. Alcohol and mitochondria: a dysfunctional relationship. Gastroenterology 122 (2002) 2049-2063
60. Gao D., Wei C., Chen L., Huang J., Yang S., and Diehl A.M. Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease. Am. J. Physiol.: Gastrointest. Liver Physiol. 287 (2004) G1070-G1077
61. Yang S., Zhu H., Li Y., Lin H., Gabrielson K., Trush M.A., and Diehl A.M. Mitochondrial adaptations to obesity-related oxidant stress. Arch. Biochem. Biophys. 378 (2000) 259-268
62. Bailey S.M., and Cunningham C.C. Acute and chronic ethanol increases reactive oxygen species generation and decreases viability in fresh, isolated rat hepatocytes. Hepatology 28 (1998) 1318-1326
63. Fernandez-Checa J.C., Kaplowitz N., Garcia-Ruiz C., Colell A., Miranda M., Mari M., Ardite E., and Morales A. GSH transport in mitochondria: defense against TNF-induced oxidative stress and alcohol-induced defect. Am. J. Physiol.: Gastrointest. Liver Physiol. 273 (1997) G7-G17
64. Mantena S.K., King A.L., Andringa K.K., Landar A., Darley-Usmar V., and Bailey S.M. Novel interactions of mitochondria and reactive oxygen/nitrogen species in alcohol mediated liver diseases. World J. Gastroenterol. 13 (2007) 4967-4973
65. Han D., Canali R., Rettori D., and Kaplowitz N. Effect of glutathione depletion on sites and topology of superoxide and hydrogen peroxide production in mitochondria. Mol. Pharmacol. 64 (2003) 1136-1144
66. Lambert, A.J., Brand, M.D. Superoxide production by NADH:ubiquinone oxidoreductase (complex I) depends on the pH gradient across the mitochondrial inner membrane. Biochem. J. 382 (2004) 511-517
67. Hinokio Y., Suzuki S., Komatu K., Ohtomo M., Onoda M., Matsumoto M., Hirai S., Sato Y., Akai H., Abe K., et al. A new mitochondrial DNA deletion associated with diabetic amyotrophy, diabetic myoatrophy and diabetic fatty liver. Muscle Nerve 3 (1995) S142-S149
68. Kawahara H., Fukura M., Tsuchishima M., and Takase S. Mutation of mitochondrial DNA in livers from patients with alcoholic hepatitis and nonalcoholic steatohepatitis. Alcohol. Clin. Exp. Res. 31 (2007) S54-S60
69. Robin M.A., Sauvage I., Grandperret T., Descatoire V., Pessayre D., and Fromenty B. Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes. FEBS Lett. 579 (2005) 6895-6902
70. Nordblom G.D., and Coon M.J. Hydrogen peroxide formation and stoichiometry of hydroxylation reactions catalyzed by highly purified liver microsomal cytochrome P-450. Arch. Biochem. Biophys. 180 (1977) 343-347
71. Adam-Vizi V. Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid. Redox Signal. 7 (2005) 1140-1149
72. Tretter L., and Adam-Vizi V. Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress. Philos. Trans. R. Soc. Lond., B Biol. Sci. 360 (2005) 2335-2345
73. Tretter L., Takacs K., Hegedus V., and Adam-Vizi V. Characteristics of alpha-glycerophosphate-evoked H2O2 generation in brain mitochondria. J. Neurochem. 100 (2007) 650-663
74. Garcia-Ruiz C., and Fernandez-Checa J.C. Mitochondrial glutathione: hepatocellular survival-death switch. J. Gastroenterol. Hepatol. 21 Suppl. 3 (2006) S3-S6
75. Garcia-Ruiz C., Morales A., Ballesta A., Rodes J., Kaplowitz N., and Fernandez-Checa J.C. Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal and perivenous rat hepatocytes. J. Clin. Invest. 94 (1994) 193-201
76. Colell A., Garcia-Ruiz C., Morales A., Ballesta A., Ookhtens M., Rodes J., Kaplowitz N., and Fernandez-Checa J.C. Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanol-treated rats: effect of membrane physical properties and S-adenosyl-l-methionine. Hepatology 26 (1997) 699-708
77. Garcia-Ruiz C., Morales A., Colell A., Ballesta A., Rodes J., Kaplowitz N., and Fernandez-Checa J.C. Feeding S-adenosyl-l-methionine attenuates both ethanol-induced depletion of mitochondrial glutathione and mitochondrial dysfunction in periportal and perivenous rat hepatocytes. Hepatology 21 (1995) 207-214
78. Colell A., Garcia-Ruiz C., Miranda M., Ardite E., Mari M., Morales A., Corrales F., Kaplowitz N., and Fernandez-Checa J.C. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology 115 (1998) 1541-1551
79. Pastorino J.G., and Hoek J.B. Ethanol potentiates tumor necrosis factor-alpha cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition. Hepatology 31 (2000) 1141-1152
80. Mari M., Caballero F., Colell A., Morales A., Caballeria J., Fernandez A., Enrich C., Fernandez-Checa J.C., and Garcia-Ruiz C. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab. 4 (2006) 185-198
81. Bailey S.M., Patel V.B., Young T.A., Asayama K., and Cunningham C.C. Chronic ethanol consumption alters the glutathione/glutathione peroxidase-1 system and protein oxidation status in rat liver. Alcohol. Clin. Exp. Res. 25 (2001) 726-733
82. Bailey S.M., Robinson G., Pinner A., Chamlee L., Ulasova E., Pompilius M., Page G.P., Chhieng D., Jhala N., Landar A., Kharbanda K.K., Ballinger S., and Darley-Usmar V. S-Adenosylmethionine prevents chronic alcohol-induced mitochondrial dysfunction in the rat liver. Am. J. Physiol.: Gastrointest. Liver Physiol. 291 (2006) G857-G867
83. Deaciuc I.V., Fortunato F., D'Souza N.B., Hill D.B., Schmidt J., Lee E.Y., and McClain C.J. Modulation of capase-3 activity and Fas ligand mRNA expression in rat liver cells in vivo by alcohol and lipopolysaccharide. Alcohol. Clin. Exp. Res. 23 (1999) 349-356
84. Sastre J., Minana J.B., Alguacil P., Malet G., Gomez-Cambronero L., Marin J.A., Vina J.R., and Vina J. Chronic ethanol feeding causes oxidative stress in rat liver mitochondria: prevention by S-adenosyl methionine. Free Radic. Res. 30 (1999) 325-327
85. Mari M., and Cederbaum A.I. CYP2E1 overexpression in HepG2 cells induces glutathione synthesis by transcriptional activation of gamma-glutamylcysteine synthetase. J. Biol. Chem. 275 (2000) 15563-15571
86. Dickinson D.A., Moellering D.R., Iles K.E., Patel R.P., Levonen A.L., Wigley A., Darley-Usmar V.M., and Forman H.J. Cytoprotection against oxidative stress and the regulation of glutathione synthesis. Biol. Chem. 384 (2003) 527-537
87. Gutierrez J., Ballinger S.W., Darley-Usmar V.M., and Landar A. Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ. Res. 99 (2006) 924-932
88. Oz H.S., Im H.J., Chen T.S., de Villiers W.J., and McClain C.J. Glutathione-enhancing agents protect against steatohepatitis in a dietary model. J. Biochem. Mol. Toxicol. 20 (2006) 39-47
89. Nobili V., Pastore A., Gaeta L.M., Tozzi G., Comparcola D., Sartorelli M.R., Marcellini M., Bertini E., and Piemonte F. Glutathione metabolism and antioxidant enzymes in patients affected by nonalcoholic steatohepatitis. Clin. Chim. Acta 355 (2005) 105-111
90. Venkatraman A., Shiva S., Wigley A., Ulasova E., Chhieng D., Bailey S.M., and Darley-Usmar V. The role of iNOS in alcohol-dependent hepatotoxicity and mitochondrial dysfunction. Hepatology 40 (2004) 565-573
91. Osei S.Y., Ahima R.S., Fabry M.E., Nagel R.L., and Bank N. Immunohistochemical localization of hepatic nitric oxide synthase in normal and transgenic sickle cell mice: the effect of hypoxia. Blood 88 (1996) 3583-3588
92. Buttery L.D., Evans T.J., Springall D.R., Carpenter A., Cohen J., and Polak J.M. Immunochemical localization of inducible nitric oxide synthase in endotoxin-treated rats. Lab. Invest. 71 (1994) 755-764
93. Kuo P.C., Alfrey E.J., Abe K.Y., Huie P., Sibley R.K., and Dafoe D.C. Cellular localization and effect of nitric oxide synthesis in a rat model of orthotopic liver transplantation. Transplantation 61 (1996) 305-312
94. Wei C.L., Khoo H.E., Lee K.H., and Hon W.M. Differential expression and localization of nitric oxide synthases in cirrhotic livers of bile duct-ligated rats. Nitric Oxide 7 (2002) 91-102
95. Koeppel T.A., Mihaljevic N., Kraenzlin B., Loehr M., Jesenofsky R., Post S., and Palma P. Enhanced iNOS gene expression in the steatotic rat liver after normothermic ischemia. Eur. Surg. Res. 39 (2007) 303-311
96. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4003-4008
97. Radi R., Cassina A., Hodara R., Quijano C., and Castro L. Peroxynitrite reactions and formation in mitochondria. Free Radic. Biol. Med. 33 (2002) 1451-1464
98. +-dependent isocitrate dehydrogenase by peroxynitrite: implications for cytotoxicity and alcohol-induced liver injury. J. Biol. Chem. 278 (2003) 51360-51371
99. *, effects of low oxygen and respiratory state. J. Biol. Chem. 278 (2003) 31603-31609
100. Poderoso J.J., Lisdero C., Schopfer F., Riobo N., Carreras M.C., Cadenas E., and Boveris A. The regulation of mitochondrial oxygen uptake by redox reactions involving nitric oxide and ubiquinol. J. Biol. Chem. 274 (1999) 37709-37716
101. Torres J., Darley-Usmar V., and Wilson M.T. Inhibition of cytochrome c oxidase in turnover by nitric oxide: mechanism and implications for control of respiration. Biochem. J. 312 Pt 1 (1995) 169-173
102. Nisoli E., Clementi E., Moncada S., and Carruba M.O. Mitochondrial biogenesis as a cellular signaling framework. Biochem. Pharmacol. 67 (2004) 1-15
103. Venkatraman A., Shiva S., Davis A.J., Bailey S.M., Brookes P.S., and Darley-Usmar V. Chronic alcohol consumption increases the sensitivity of rat liver mitochondrial respiration to inhibition by nitric oxide. Hepatology 38 (2003) 141-147
104. Thayer W.S., and Rubin E. Molecular alterations in the respiratory chain of rat liver after chronic ethanol consumption. J. Biol. Chem. 256 (1981) 6090-6097
105. Shiva S., Oh J.Y., Landar A.L., Ulasova E., Venkatraman A., Bailey S.M., and Darley-Usmar V.M. Nitroxia: the pathological consequence of dysfunction in the nitric oxide-cytochrome c oxidase signaling pathway. Free Radic. Biol. Med. 38 (2005) 297-306
106. McKim S.E., Gabele E., Isayama F., Lambert J.C., Tucker L.M., Wheeler M.D., Connor H.D., Mason R.P., Doll M.A., Hein D.W., and Arteel G.E. Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. Gastroenterology 125 (2003) 1834-1844
107. Liu J., and Waalkes M.P. Nitric oxide and chemically induced hepatotoxicity: beneficial effects of the liver-selective nitric oxide donor, V-PYRRO/NO. Toxicology 208 (2005) 289-297
108. Duranski M.R., Elrod J.W., Calvert J.W., Bryan N.S., Feelisch M., and Lefer D.J. Genetic overexpression of eNOS attenuates hepatic ischemia-reperfusion injury. Am. J. Physiol., Heart Circ. Physiol. 291 (2006) H2980-H2986
109. Rivera-Chavez F.A., Toledo-Pereyra L.H., Dean R.E., Crouch L., and Ward P.A. Exogenous and endogenous nitric oxide but not iNOS inhibition improves function and survival of ischemically injured livers. J. Invest. Surg. 14 (2001) 267-273
110. de Oliveira C.P., Simplicio F.I., de Lima V.M., Yuahasi K., Lopasso F.P., Alves V.A., Abdalla D.S., Carrilho F.J., Laurindo F.R., and de Oliveira M.G. Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats. World J. Gastroenterol. 12 (2006) 1905-1911
111. de Oliveira C.P., Stefano J.T., de Lima V.M., de Sa S.V., Simplicio F.I., de Mello E.S., Correa-Giannella M.L., Alves V.A., Laurindo F.R., de Oliveira M.G., Giannella-Neto D., and Carrilho F.J. Hepatic gene expression profile associated with non-alcoholic steatohepatitis protection by S-nitroso-N-acetylcysteine in ob/ob mice. J. Hepatol. 45 (2006) 725-733
112. Lang Jr. J.D., Teng X., Chumley P., Crawford J.H., Isbell T.S., Chacko B.K., Liu Y., Jhala N., Crowe D.R., Smith A.B., Cross R.C., Frenette L., Kelley E.E., Wilhite D.W., Hall C.R., Page G.P., Fallon M.B., Bynon J.S., Eckhoff D.E., and Patel R.P. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J. Clin. Invest. 117 (2007) 2583-2591
113. Gladwin M.T., Raat N.J., Shiva S., Dezfulian C., Hogg N., Kim-Shapiro D.B., and Patel R.P. Nitrite as a vascular endocrine nitric oxide reservoir that contributes to hypoxic signaling, cytoprotection, and vasodilation. Am. J. Physiol., Heart Circ. Physiol. 291 (2006) H2026-H2035
114. Duranski M.R., Greer J.J., Dejam A., Jaganmohan S., Hogg N., Langston W., Patel R.P., Yet S.F., Wang X., Kevil C.G., Gladwin M.T., and Lefer D.J. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J. Clin. Invest. 115 (2005) 1232-1240
115. Karaa A., Kamoun W.S., and Clemens M.G. Chronic ethanol sensitizes the liver to endotoxin via effects on endothelial nitric oxide synthase regulation. Shock 24 (2005) 447-454
116. Wang X., and Abdel-Rahman A.A. Effect of chronic ethanol administration on hepatic eNOS activity and its association with caveolin-1 and calmodulin in female rats. Am. J. Physiol.: Gastrointest. Liver Physiol. 289 (2005) G579-G585
117. Nanji A.A., Greenberg S.S., Tahan S.R., Fogt F., Loscalzo J., Hossein Sadrzadeh S.M., Xie J., and Stamler J.S. Nitric oxide production in experimental alcoholic liver disease: role in protection from injury. Gastroenterology 109 (1995) 899-907
118. Nanji A.A., Jokelainen K., Lau G.K., Rahemtulla A., Tipoe G.L., Polavarapu R., and Lalani E.N. Arginine reverses ethanol-induced inflammatory and fibrotic changes in liver despite continued ethanol administration. J. Pharmacol. Exp. Ther. 299 (2001) 832-839
119. Haynes V., Elfering S., Traaseth N., and Giulivi C. Mitochondrial nitric-oxide synthase: enzyme expression, characterization, and regulation. J. Bioenerg. Biomembr. 36 (2004) 341-346
120. Haynes V., Elfering S.L., Squires R.J., Traaseth N., Solien J., Ettl A., and Giulivi C. Mitochondrial nitric-oxide synthase: role in pathophysiology. IUBMB Life 55 (2003) 599-603
121. Shiva S., Huang Z., Grubina R., Sun J., Ringwood L.A., MacArthur P.H., Xu X., Murphy E., Darley-Usmar V.M., and Gladwin M.T. Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ. Res. 100 (2007) 654-661
122. Wilfred de Alwis N.M., and Day C.P. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. Semin. Liver Dis. 27 (2007) 44-54
123. Stickel F., and Osterreicher C.H. The role of genetic polymorphisms in alcoholic liver disease. Alcohol Alcohol. 41 (2006) 209-224
124. Zintzaras E., Stefanidis I., Santos M., and Vidal F. Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease?. Hepatology 43 (2006) 352-361
125. Degoul F., Sutton A., Mansouri A., Cepanec C., Degott C., Fromenty B., Beaugrand M., Valla D., and Pessayre D. Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease. Gastroenterology 120 (2001) 1468-1474
126. Nahon P., Sutton A., Pessayre D., Rufat P., Degoul F., Ganne-Carrie N., Ziol M., Charnaux N., N'Kontchou G., Trinchet J.C., Gattegno L., and Beaugrand M. Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death. Clin. Gastroenterol. Hepatol. 3 (2005) 292-298
127. Sutton A., Imbert A., Igoudjil A., Descatoire V., Cazanave S., Pessayre D., and Degoul F. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet. Genomics 15 (2005) 311-319
128. Sutton A., Khoury H., Prip-Buus C., Cepanec C., Pessayre D., and Degoul F. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 13 (2003) 145-157
129. Sutton A., Nahon P., Pessayre D., Rufat P., Poire A., Ziol M., Vidaud D., Barget N., Ganne-Carrie N., Charnaux N., Trinchet J.C., Gattegno L., and Beaugrand M. Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis. Cancer Res. 66 (2006) 2844-2852
130. Koch O., Farre S., De Leo M.E., Palozza P., Palazzotti B., Borrelo S., Palombini G., Cravero A., and Galeotti T. Regulation of manganese superoxide dismutase (MnSOD) in chronic experimental alcoholism: effects of vitamin E-supplemented and -deficient diets. Alcohol Alcohol. 35 (2000) 159-163
131. Koch O.R., De Leo M.E., Borrello S., Palombini G., and Galeotti T. Ethanol treatment up-regulates the expression of mitochondrial manganese superoxide dismutase in rat liver. Biochem. Biophys. Res. Commun. 201 (1994) 1356-1365
132. Stewart S.F., Leathart J.B., Chen Y., Daly A.K., Rolla R., Vay D., Mottaran E., Vidali M., Albano E., and Day C.P. Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis. Hepatology 36 (2002) 1355-1360
133. Namikawa C., Shu-Ping Z., Vyselaar J.R., Nozaki Y., Nemoto Y., Ono M., Akisawa N., Saibara T., Hiroi M., Enzan H., and Onishi S. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J. Hepatol. 40 (2004) 781-786
134. Hines I.N., and Wheeler M.D. Recent advances in alcoholic liver disease. III. Role of the innate immune response in alcoholic hepatitis. Am. J. Physiol.: Gastrointest. Liver Physiol. 287 (2004) G310-G314
135. Thurman R.G. Mechanisms of hepatic toxicity. II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am. J. Physiol.: Gastrointest. Liver Physiol. 275 (1998) G605-G611
136. Jarvelainen H.A., Orpana A., Perola M., Savolainen V.T., Karhunen P.J., and Lindros K.O. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 33 (2001) 1148-1153
137. Day C.P. CD14 promoter polymorphism associated with risk of NASH. J. Hepatol. 36 (2002) 21
138. * in the 5′. flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am. J. Respir. Cell Mol. Biol. 20 (1999) 976-983
139. Leathart J.B., Day C.P., and Daly A.K. No association between functional SNP's in the endotoxin receptors CD14 and TLR4 and alcoholic liver disease (ALD): is endotoxin important in the pathogenesis of ALD in humans?. Hepatology 34 (2001) 459A
140. Martins A., Cortez-Pinto H., Machado M., Goncalves M.S., Soren S., Marques-Vidal P., de Moura M.C., and Camilo M.E. Are genetic polymorphisms of tumour necrosis factor alpha, interleukin-10, CD14 endotoxin receptor or manganese superoxide dismutase associated with alcoholic liver disease?. Eur. J. Gastroenterol. Hepatol. 17 (2005) 1099-1104
141. Dixon J.B., Bhathal P.S., Jonsson J.R., Dixon A.F., Powell E.E., and O′Brien P.E. Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J. Hepatol. 39 (2003) 967-971
142. Pravenec M., Hyakukoku M., Houstek J., Zidek V., Landa V., Mlejnek P., Miksik I., Dudova-Mothejzikova K., Pecina P., Vrbacky M., Drahota Z., Vojtiskova A., Mracek T., Kazdova L., Oliyarnyk O., Wang J., Ho C., Qi N., Sugimoto K., and Kurtz T. Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains. Genome Res. 17 (2007) 1319-1326
143. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39 (2005) 359-407
144. Tome S., and Lucey M.R. Review article: current management of alcoholic liver disease. Aliment. Pharmacol. Ther. 19 (2004) 707-714
145. Bergheim I., Guo L., Davis M.A., Lambert J.C., Beier J.I., Duveau I., Luyendyk J.P., Roth R.A., and Arteel G.E. Metformin prevents alcohol-induced liver injury in the mouse: critical role of plasminogen activator inhibitor-1. Gastroenterology 130 (2006) 2099-2112
146. Hernandez R., Teruel T., de Alvaro C., and Lorenzo M. Rosiglitazone ameliorates insulin resistance in brown adipocytes of Wistar rats by impairing TNF-alpha induction of p38 and p42/p44 mitogen-activated protein kinases. Diabetologia 47 (2004) 1615-1624
147. Iwata M., Haruta T., Usui I., Takata Y., Takano A., Uno T., Kawahara J., Ueno E., Sasaoka T., Ishibashi O., and Kobayashi M. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator-activated receptor-gamma. Diabetes 50 (2001) 1083-1092
148. Murase K., Odaka H., Suzuki M., Tayuki N., and Ikeda H. Pioglitazone time-dependently reduces tumour necrosis factor-alpha level in muscle and improves metabolic abnormalities in Wistar fatty rats. Diabetologia 41 (1998) 257-264
149. Leclercq I.A., Lebrun V.A., Starkel P., and Horsmans Y.J. Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARgamma agonist pioglitazone. Lab. Invest. 87 (2007) 56-65
150. Tahan V., Eren F., Avsar E., Yavuz D., Yuksel M., Emekli E., Imeryuz N., Celikel C., Uzun H., Haklar G., and Tozun N. Rosiglitazone attenuates liver inflammation in a rat model of nonalcoholic steatohepatitis. Dig. Dis. Sci. (2007)
151. Tomita K., Azuma T., Kitamura N., Nishida J., Tamiya G., Oka A., Inokuchi S., Nishimura T., Suematsu M., and Ishii H. Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met. Gastroenterology 126 (2004) 873-885
152. Fischer M., You M., Matsumoto M., and Crabb D.W. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J. Biol. Chem. 278 (2003) 27997-28004
153. Garcia-Ruiz I., Rodriguez-Juan C., Diaz-Sanjuan T., Martinez M.A., Munoz-Yague T., and Solis-Herruzo J.A. Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice. Hepatology 46 (2007) 414-423
154. Caldwell S.H., Patrie J.T., Brunt E.M., Redick J.A., Davis C.A., Park S.H., and Neuschwander-Tetri B.A. The effects of 48 weeks of rosiglitazone on hepatocyte mitochondria in human nonalcoholic steatohepatitis. Hepatology 46 (2007) 1101-1107
155. Harrison S.A., Torgerson S., Hayashi P., Ward J., and Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 98 (2003) 2485-2490
156. Hasegawa T., Yoneda M., Nakamura K., Makino I., and Terano A. Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment. Pharmacol. Ther. 15 (2001) 1667-1672
157. Lavine J.E. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J. Pediatr. 136 (2000) 734-738
158. Sanyal A.J., Mofrad P.S., Contos M.J., Sargeant C., Luketic V.A., Sterling R.K., Stravitz R.T., Shiffman M.L., Clore J., and Mills A.S. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Clin. Gastroenterol. Hepatol. 2 (2004) 1107-1115
159. Devaraj S., and Jialal I. Failure of vitamin E in clinical trials: is gamma-tocopherol the answer?. Nutr. Rev. 63 (2005) 290-293
160. Jiang Q., and Ames B.N. Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB J. 17 (2003) 816-822
161. Brown S.E., Ross M.F., Sanjuan-Pla A., Manas A.R., Smith R.A., and Murphy M.P. Targeting lipoic acid to mitochondria: synthesis and characterization of a triphenylphosphonium-conjugated alpha-lipoyl derivative. Free Radic. Biol. Med. 42 (2007) 1766-1780
162. Cocheme H.M., Kelso G.F., James A.M., Ross M.F., Trnka J., Mahendiran T., Asin-Cayuela J., Blaikie F.H., Manas A.R., Porteous C.M., Adlam V.J., Smith R.A., and Murphy M.P. Mitochondrial targeting of quinones: therapeutic implications. Mitochondrion 7 Suppl. (2007) S94-S102
163. Murphy M.P. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 629-656
164. Adlam V.J., Harrison J.C., Porteous C.M., James A.M., Smith R.A., Murphy M.P., and Sammut I.A. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J. 19 (2005) 1088-1095
165. Covey M.V., Murphy M.P., Hobbs C.E., Smith R.A., and Oorschot D.E. Effect of the mitochondrial antioxidant, mito vitamin E, on hypoxic-ischemic striatal injury in neonatal rats: a dose-response and stereological study. Exp. Neurol. 199 (2006) 513-519
166. Ronis M.J., Butura A., Sampey B.P., Shankar K., Prior R.L., Korourian S., Albano E., Ingelman-Sundberg M., Petersen D.R., and Badger T.M. Effects of N-acetylcysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition. Free Radic. Biol. Med. 39 (2005) 619-630
167. Kang Y.J., and Zhou Z. Zinc prevention and treatment of alcoholic liver disease. Mol. Aspects Med. 26 (2005) 391-404
168. Zhou Z., Wang L., Song Z., Saari J.T., McClain C.J., and Kang Y.J. Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am. J. Pathol. 166 (2005) 1681-1690
169. Song Z., Deaciuc I., Song M., Lee D.Y., Liu Y., Ji X., and McClain C. Silymarin protects against acute ethanol-induced hepatotoxicity in mice. Alcohol. Clin. Exp. Res. 30 (2006) 407-413
170. Lindor K.D., Kowdley K.V., Heathcote E.J., Harrison M.E., Jorgensen R., Angulo P., Lymp J.F., Burgart L., and Colin P. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology 39 (2004) 770-778
171. Cave M., Deaciuc I., Mendez C., Song Z., Joshi-Barve S., Barve S., and McClain C. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. J. Nutr. Biochem. 18 (2007) 184-195
172. Comar K.M., Sterling, and R.K. Review article: Drug therapy for non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 23 (2006) 207-215
173. Federico A., Trappoliere M., and Loguercio C. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives. Dig. Liver Dis. 38 (2006) 789-801
174. Reuben A. Alcohol and the liver. Curr. Opin. Gastroenterol. 23 (2007) 283-291
175. Mato J.M., Alvarez L., Ortiz P., and Pajares M.A. S-Adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol. Ther. 73 (1997) 265-280
176. Lu S.C., Huang Z.Z., Yang H., Mato J.M., Avila M.A., and Tsukamoto H. Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. Am. J. Physiol.: Gastrointest. Liver Physiol. 279 (2000) G178-G185
177. Barak A.J., Beckenhauer H.C., and Tuma D.J. Methionine synthase: a possible prime site of the ethanolic lesion in liver. Alcohol 26 (2002) 65-67
178. Perez-Mato I., Castro C., Ruiz F.A., Corrales F.J., and Mato J.M. Methionine adenosyltransferase S-nitrosylation is regulated by the basic and acidic amino acids surrounding the target thiol. J. Biol. Chem. 274 (1999) 17075-17079
179. Ruiz F., Corrales F.J., Miqueo C., and Mato J.M. Nitric oxide inactivates rat hepatic methionine adenosyltransferase in vivo by S-nitrosylation. Hepatology 28 (1998) 1051-1057
180. Lieber C.S. S-Adenosyl-l-methionine: its role in the treatment of liver disorders. Am. J. Clin. Nutr. 76 Suppl. (2002) 1183S-1187S
181. Garcia-Ruiz C., Colell A., Morales A., Kaplowitz N., and Fernandez-Checa J.C. Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-κB: studies with isolated mitochondria and rat hepatocytes. Mol. Pharmacol. 48 (1995) 825-834
182. Lieber C.S., DeCarli L.M., Mak K.M., Kim C.I., and Leo M.A. Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin. Hepatology 12 (1990) 1390-1398
183. Mato J.M., Camara J., Fernandez de Paz J., Caballeria L., Coll S., Caballero A., Garcia-Buey L., Beltran J., Benita V., Caballeria J., Sola R., Moreno-Otero R., Barrao F., Martin-Duce A., Correa J.A., Pares A., Barrao E., Garcia-Magaz I., Puerta J.L., Moreno J., Boissard G., Ortiz P., and Rodes J. S-Adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J. Hepatol. 30 (1999) 1081-1089
184. Lu S.C., Alvarez L., Huang Z.Z., Chen L., An W., Corrales F.J., Avila M.A., Kanel G., and Mato J.M. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 5560-5565
185. Martinez-Chantar M.L., Corrales F.J., Martinez-Cruz L.A., Garcia-Trevijano E.R., Huang Z.Z., Chen L., Kanel G., Avila M.A., Mato J.M., and Lu S.C. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J. 16 (2002) 1292-1294
186. Santamaria E., Avila M.A., Latasa M.U., Rubio A., Martin-Duce A., Lu S.C., Mato J.M., and Corrales F.J. Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 3065-3070
187. Song Z., Zhou Z., Song M., Uriarte S., Chen T., Deaciuc I., and McClain C.J. Alcohol-induced S-adenosylhomocysteine accumulation in the liver sensitizes to TNF hepatotoxicity: possible involvement of mitochondrial S-adenosylmethionine transport. Biochem. Pharmacol. 74 (2007) 521-531
188. Ji C., and Kaplowitz N. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 124 (2003) 1488-1499
189. Kharbanda K.K., Mailliard M.E., Baldwin C.R., Beckenhauer H.C., Sorrell M.F., and Tuma D.J. Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway. J. Hepatol. 46 (2007) 314-321
190. Song Z., Deaciuc I., Zhou Z., Song M., Chen T., Hill D., and McClain C.J. Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis. Am. J. Physiol. Gastrointest. Liver Physiol. 293 (2007) G894-G902
191. Abdelmalek M.F., Angulo P., Jorgensen R.A., Sylvestre P.B., and Lindor K.D. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. Am. J. Gastroenterol. 96 (2001) 2711-2717
192. Mato J.M., and Lu S.C. Homocysteine, the bad thiol. Hepatology 41 (2005) 976-979
193. Craig S.A. Betaine in human nutrition. Am. J. Clin. Nutr. 80 (2004) 539-549
194. Werstuck G.H., Lentz S.R., Dayal S., Hossain G.S., Sood S.K., Shi Y.Y., Zhou J., Maeda N., Krisans S.K., Malinow M.R., and Austin R.C. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin. Invest. 107 (2001) 1263-1273
195. Gulsen M., Yesilova Z., Bagci S., Uygun A., Ozcan A., Ercin C.N., Erdil A., Sanisoglu S.Y., Cakir E., Ates Y., Erbil M.K., Karaeren N., and Dagalp K. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 20 (2005) 1448-1455
196. King A.L., Eccleston H.E., Andringa K.K., Tuma D.J., Kharbanda K.K., and Bailey S.M. S-Adenosylmethionine and betaine prevent chronic alcohol associated losses in hepatic mitochondria respiratory complex content. Free Radic. Biol. Med. 41 (2006) S23